Greenhill & Co Inc (GHL) Jumps 10.16% on January 28

Equities Staff |

Greenhill & Co Inc (GHL) was among the biggest gainers on the Russell 2000 for Thursday January 28 as the stock popped 10.16% to $23.85, representing a gain of $2.2 per share. Some 895,035 shares traded hands on 7,120 trades, compared with an average daily volume of 406,371 shares out of a total float of 29.33 million. The stock opened at $24.89 and traded with an intraday range of $25.39 to $23.00.

After today's gains, Greenhill & Co Inc reached a market cap of $699.41 million. Greenhill & Co Inc has had a trading range between $43.99 and $19.74 over the last year, and it had a 50-day SMA of $25.33 and a 200-day SMA of $32.64.

The stock has a P/E Ratio of 20.2.

Greenhill & Co Inc is an investment bank providing financial advice on mergers, acquisitions, restructurings, financing and capital raising to corporations, partnerships, institutions and governments.

Greenhill & Co Inc is based out of New York, NY and has some 305 employees. Its CEO is Scott L. Bok.

For a complete fundamental analysis analysis of Greenhill & Co Inc, check out’s Stock Valuation Analysis report for GHL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…